Detalles de la búsqueda
1.
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis.
Lancet Oncol
; 22(9): 1265-1274, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34391508
2.
Clinical manifestations and long-term prognosis of Good syndrome: Results from a single-center cohort study from China.
Mod Rheumatol
; 31(5): 1019-1024, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428506
3.
Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation.
Clin Immunol
; 213: 108377, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135278
4.
Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis.
BMC Med
; 18(1): 87, 2020 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32306958
5.
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer.
Transl Lung Cancer Res
; 13(5): 1032-1046, 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38854937
6.
Real-Time Seizure Detection Using Behind-the-Ear Wearable System.
J Clin Neurophysiol
; 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376923
7.
Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis.
Nat Commun
; 15(1): 2107, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453911
8.
Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy.
Cancer Lett
; 565: 216239, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211066
9.
Efficacy and toxicity profile of first-line treatment for extensive-stage small cell lung cancer: A Bayesian network meta-analysis.
Cancer Med
; 12(9): 10230-10242, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951654
10.
Perfusable cell-laden matrices to guide patterning of vascularization in vivo.
Biomater Sci
; 11(2): 461-471, 2023 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477015
11.
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.
Clin Cancer Res
; 29(20): 4098-4108, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37581611
12.
Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies.
Front Oncol
; 12: 873994, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35719973
13.
Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer.
Front Immunol
; 13: 1058819, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36439167
14.
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers.
Sci Adv
; 7(21)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34138742
15.
Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study.
Ann Transl Med
; 8(21): 1415, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33313160
16.
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer.
Cancer Immunol Res
; 8(1): 146-154, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31719056
17.
Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
Front Physiol
; 9: 452, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29765332
Resultados
1 -
17
de 17
1
Próxima >
>>